ArticleTranslational lung cancer research2025
Comparative study of bronchoscopic and CT-guided percutaneous microwave ablation for inoperable non-small cell lung cancer.
Article in Translational lung cancer research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Robotic Bronchoscopic Lung Ablation: Can Evidence Generation Keep Pace with Technological Innovation?Cardiovascular and interventional radiology · 2026Article
- Bronchoscopic Ablation and Intratumoral Therapies for Lung Cancer: Expanding Local Treatment Beyond Surgical Resection.Cancers · 2026Review
- Annual progress in transbronchial diagnosis and treatment of pulmonary malignant tumors [2025]: a narrative review.Translational lung cancer research · 2026Review
- Research status and trend of lung cancer ablation therapy: a bibliometric analysis from 2002 to 2025.Journal of thoracic disease · 2026Article
- Single-center experience in combined video-assisted thoracic surgery with transbronchial microwave ablation-a novel approach to multifocal lung nodules.Frontiers in surgery · 2026Article
- Robotic-assisted and electromagnetic navigation bronchoscopy for multi-focal lung cancers: a narrative review.Translational lung cancer research · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Patients with inoperable stage I non-small cell lung cancer (NSCLC) have limited treatment options. Microwave ablation (MWA) offers a promising alternative. This study aims to compare the clinical efficacy and safety of computed tomography (CT)-guided percutaneous transthoracic microwave ablation (PTMA) and bronchoscopic transbronchial microwave ablation (BTMA). Methods: A total of 126 patients with stage I NSCLC who were not candidates for surgery underwent PTMA or BTMA. Outcomes evaluated included complete ablation rate, local control rate (LCR), progression-free survival (PFS), technical success, procedure-related complications, and lesion size changes. Subgroup analyses were conducted based on age, nodule size, and nodule density. Results: The 6-month complete ablation rates were similar in the BTMA and PTMA groups (96.7% Conclusions: Both PTMA and BTMA are effective treatment options for inoperable stage I NSCLC. BTMA offers similar efficacy with fewer complications and may be preferable in selected patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.